Medicines
SmPC of 27/03/2024
SULFUR GRANIONS 19,5 mg/2 ml, oral solution
Composition
For one ampoule of 2 ml:
Sulfur (as sodium thiosulfate): 19,50 mg
Excipient with known effect: sodium
Amylose, glycerol, xanthan gum, purified water.
Indications
Used as a terrain modifier, in particular during recurrent skin, rheumatological and ENT conditions.
Dosage and administration
RESERVED FOR ADULTS.
Dosage
The recommended dose is 1 to 2 ampoules per day.
Method and route of administration
Oral use.
It is advised to take the contents of the ampoules diluted in a glass of water.
To be taken in the morning, away from meals.
Contraindications
- Hypersensitivity to the active substance or to any of the excipients listed in section Composition
Warnings and precautions
Treatment with this trace mineral element does not replace any specific treatment that may be needed. This medicine contains sodium. The sodium content is less than 1 mmol per dose, meaning it is essentially "sodium-free".
Interactions
The data available to date do not suggest the existence of clinically significant interactions.
Fertility, pregnancy and breastfeeding
Pregnancy
In the absence of experimental and clinical data and as a precautionary measure, use of this medicine should be avoided during pregnancy.
Breast-feeding
In the absence of experimental and clinical data and as a precaution, use of this medicine should be avoided during breastfeeding.
Adverse effects
No adverse effects have been reported with the use of SULFUR GRANIONS 19,5 mg/2 ml, oral solution in ampoule.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system: National Agency for the Safety of Medicines and Health Products (ANSM) and the network of Regional Pharmacovigilance Centres - Website: https://signalement.social-sante.gouv.fr/.
Overdose
No cases of overdose have been reported; however, a possible overdose will cause a laxative effect.
Prescription, supply and reimbursement
| Marketing authorisation (AMM) |
|
GRANIONS EA-PHARMA Laboratory
Le Parador II
5, allée Crovetto-Frères. 98000 Monaco
Tel: 00 377 92 05 76 30
Source: VIDAL · Updated on 10/11/2026. This information does not replace advice from a healthcare professional.
